Dallas, TX (PRWEB) February 25, 2013
The prescription drug resource center DrugRisk.com is alerting those patients who’ve taken the diabetes drug Actos of updated legal news on the site showing trial will commence this week in the first of thousands of lawsuits filed over bladder cancer.
“The goal of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. By following the cases of others, patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.
The resource center has added Actos warnings by both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of bladder cancer. The drug has also been banned in France and Germany.***
In DrugRisk legal news, more than 1,200 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals in a special multi-district federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).
Now, the resource center is reporting that another group of Actos cases are set to kick off this week as a California State court begins jury selection.**** Bloomberg estimates as many as 3,000 Actos lawsuits await trial in total over allegations of bladder cancer.
Lawyers are still helping those who have questions about their legal options. Anyone who was diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled Actos lawsuits.
For more information on the research, side effects and litigation news related to Actos and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.